baber/WOPTO huggingface dataset:
Patent NZ-503621-A (NZ)
Title: Two pack system for the preparation of peracid compositions for teat-dips
Inventor: SIMMS ROBERT ASHLEY
IPC: A01N37/16
Filed: 1998-09-09
Abstract: Described is a two-pack system for the preparation of peracid compositions for the disinfection, cleaning, and protection of cow's teats before and after milking.  A first component of the product comprises an aqueous equilibrated solution of a lower aliphatic peracid and a second component comprises an aqueous solution containing an emollient, food grade fragrance, food grade dye, food grade thickening agent, and alkali buffer.  The two packs can be mixed to produce a consistent solution of known quality for reducing disease on cow's teats that is nonirritant, has low odour and/or contains a food grade fragrance and may be coloured, thickened, pH buffered, and is effective for at least 24 hours after mixing.
Patent NZ-506247-A (NZ)
Title: Fungicidal 7-(alkyl, alkenyl, alkadienyl, cycloalkyl, cycloalkenyl or aryl)-[1,2,4]triazolo[1,5-a]pyrimidines
Inventor: PFRENGLE WALDEMAR
IPC: A01N43/00
Filed: 1999-02-09
Abstract: A compound of the formula (I), wherein: R1  represents  an  optionally substituted  alkyl,  alkenyl, alkynyl,   alkadienyl,  or  aryl  group,  or  an  optionally substituted cycloalkyl or cycloalkenyl group, in  which  one CH2  group may also be replace by O, S or NR2, in  which  R2 represents a hydrogen atom or an alkyl group; X  represents  a  hydrogen or halogen atom,  or  a  hydroxy, alkoxy,  aryloxy, aralkyloxy, haloalkoxy, alkylthio,  cyano, amino, alkylamino or dialkylamino group; L1,  L2,  L3,  L4  and  L5  each independently  represent  a hydrogen or halogen atom or an optionally substituted  alkyl or alkoxy group or a nitro or cyano group. Also described is a fungicidal composition which comprises a carrier,  and  as  active agent, at least  one  compound  of formula (I). Also described is the use of the compound of formula (I)  as a fungicide.
Patent NZ-506353-A (NZ)
Title: Hip protector
Inventor: OLSEN HANS
IPC: A41D27/26
Filed: 1999-02-18
Abstract: A  device  (1) for protecting against lesions,  mainly bone  lesions  and especially fracture of the  neck  of  the femur,  comprising: shell means (2), a fastening means  (22) and  an  adhesive  means (4).  The shell  means  (2)  has  a concave  and a convex side.  The adhesive means comprises  a skin-friendly  adhesive (18) suitable for long-term  contact with  the  skin.  The connecting part (3) of  the  fastening means  (22)  is  permanently fixed to the  shell  means  (2) close  to  a  peripheral zone (9) on the  concave  side  (6) thereof.   The fastening of the adhesive means  (4)  to  the coupling part (20) of the fastening means is done by a  non- permanent attachment.
Patent NZ-510329-A (NZ)
Title: Retroviral protease inhibiting compounds
Inventor: SHAM HING LEUNG
IPC: C07D277/34
Filed: 1996-12-06
Abstract: An HIV protease inhibiting compound comprising a substituent of formula I; Wherein R3 is loweralkyl, hydroxyalkyl, or cycloalkylalkyl; and R5 is selected from a) to i) Wherein n is 1, 2 or 3, m is 1, 2 or 3, m' is 1 or 2, X is O, S or NH, Y is Ch2, O, S or N(R6) wherein R6 is hydrogen, loweralkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl, Y" is CH2 or N(R6") wherein R6" is hydrogen, loweralkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl, Y' is N(R6') wherein R6' is hydrogen, loweralkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl, and Z is O, S or NH.
Patent NZ-510380-A (NZ)
Title: Antiviral combinations of lamivudine and adefovir (PMEA)
Inventor: CONDREAY LYNN D
IPC: A61K31/506
Filed: 1999-09-17
Abstract: Therapeutic combinations comprising (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-pyrimidin-2-one (also known as lamivudine) and a second therapeutic agent selected from (9-[(R)-2-(phosphonomethoxy)ethyl]adenine (also known as PMEA or adefovir) and bis(pivaloyloxymethyl)(9-[(R)-2-(phosphonomethoxy)ethyl]adenine (the oral prodrug of PMEA, adefovir dipivoxil) or pharmecutically acceptable derivatives thereof, wherein (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-pyrimidin-2-one and the second therapeutic agent are present in the range 40:1 to 1:1 by weight are disclosed. As these therapeutic combinations have anti-hepatitis B virus (HBV) activity, pharmaceutical compositions containing said combinations and their use in the treatment of HBV infections including infections with HBV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors are also disclosed.
Patent NZ-510506-A (NZ)
Title: Antiviral purine derivatives
Inventor: MCGUIGAN CHRISTOPHER
IPC: A61P31/14
Filed: 1999-09-27
Abstract: Compounds of formula (I), wherein: Ar is an aryl group, R1 and R2 are each independently H, alkyl and aryl groups, X is selected from O, NH, NR4 and S, wherein R4 is alkyl or aryl, R5 is selected from H, alkyl and aryl groups, wherein R1 and R5 may together form a 5 or 6 membered ring, and R3 is selected from H, alkyl, aryl, heterocyclic and polycyclic groups. The compounds are used in the manufacture of a medicament for the treatment or prophylaxis of a viral infection.
Patent NZ-511037-A (NZ)
Title: Methods for treatment of degenerative retinal diseases
Inventor: TIMMERS ADRIAN M
IPC: C12N9/04
Filed: 1999-09-17
Abstract: A polynucleotide comprising a retinal epithelial cell-specific promoter operably linked to a nucleic acid segment that encodes a photoreceptor degradation-inhibitory polypeptide.
Patent NZ-511256-A (NZ)
Title: Production of calcium hydrogenphosphate or monocalcium phosphate from calcium phosphate
Inventor: DE WAAL JAN C
IPC: C01B25/32
Filed: 1998-09-23
Abstract: A method of preparing dicalcium phosphate from calcium phosphate comprises:  a) reacting the calcium phosphate with a suitable mineral acid to form the corresponding calcium salt and phosphoric acid; b) hydrolyzing the calcium salt of step a) to form the corresponding hydrolyzed form of calcium  and the mineral acid of setup a) or its salt; c) where the salt of the mineral acid is formed in step b), electrolyzing such salt to form the corresponding mineral acid together with an alkali; d) recycling the mineral acid of step b) or c) to step a) and e) reacting the calcium alkali of step b) with the phosphoric acid of step a) to form dicalcium phosphate. A method of preparing monocalcium phosphate (MCP) fertiliser comprises:  i) reacting the ore containing calcium phosphate with a sulphuric acid  to produce MCP, calcium sulphate and water; ii) reacting the MCP with oxalic acid to produce calcium oxalate and phosphoric acid and iii) reacting additional ore containing tricalcium phosphate with the phosphoric acid produced in step b) to produce MCP;
Patent NZ-517455-A (NZ)
Title: Determination of likely torsion values for molecular conformers, computational molecular geometry
Inventor: SMELLIE ANDREW S
IPC: G06F17/30
Filed: 1997-06-24
Abstract: A method for determining likely torsion values for each conformer in a plurality of conformers, each conformer having a plurality of particular chemical bond representations, said method comprising the steps: - associating with each conformer a plurality of internal coordinates, each of said internal coordinates having a plurality of characteristic values corresponding to each chemical bond representation in said conformer; - determining for each conformer, an energy difference level representing an incremental amount of potential energy above a first nominal energy value, said incremental amount of potential energy required to maintain each chemical bond representation at each of said plurality of characteristic values; - for each internal coordinate, for each characteristic value in said plurality of characteristic values, selecting a conformer having a corresponding minimum energy difference level, said corresponding energy difference level selected from said energy difference level computed for each conformer, to form a plurality of corresponding minimum energy difference levels; - for each characteristic value, determining a maximum energy difference value from among said plurality of corresponding minimum energy difference levels, to form a plurality of maximum energy difference values; - for each internal coordinate, selecting a plurality of likely values from said plurality of characteristic values, wherein said plurality of likely values in said internal coordinate correspond to a second nominal energy value from said corresponding maximum energy difference levels.
Patent NZ-517903-A (NZ)
Title: One dose intranasal influenza virus vaccine with split influenza viral antigens
Inventor: FRIEDE MARTIN
IPC: A61K47/28
Filed: 2000-09-22
Abstract: Disclosed is the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose intranasal vaccination against influenza, wherein the one-dose vaccination meets at least 2 of the three European Union Criteria for sero conversion rate, sero protection rate and sero conversion factor, for the or all of the strains of influenza present. Further provided are methods for the production of the vaccine and a pharmaceutical kit comprising an intranasal administration device and the one-dose vaccine.
Patent NZ-518105-A (NZ)
Title: Pneumatic spring with L-shaped gas chamber and volume adjustment device
Inventor: FILLEUL MAURICE LYNDON
IPC: A47B9/02
Filed: 2002-03-28
Abstract: First chamber 4 is in fluid communication with and is oriented to second chamber 5 at 70 to 110o, and typically 90o. Actuating member 5 extends slidably through the lower end of chamber 4. An adjustment device is provided for varying the volume so as to adjust pressurised gas volume in the chambers 4 and 9, thereby adjusting the force on actuating member 5. The spring is typically used for desk height adjustment as shown.
Patent NZ-526177-A (NZ)
Title: Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
Inventor: PEUKERT STEFAN
IPC: C07D213/81
Filed: 2001-11-17
Abstract: Ortho-substituted and meta-substituted bis-aryl compounds of formula (I) are disclosed, wherein the variables A1 to A8, R(1), R(2), R(3), R(4), R(30) and R(31) are as defined in the specification. These compounds are especially well suited for use as antiarrhythmic active substances, in particular, for the treatment and prophylaxis of atrial arrhythmias, e.g. atrial fibrillations (AF) or atrial flutters.
Patent NZ-532646-A (NZ)
Title: Internally cooled tool pack
Inventor: BLUE RODNEY
IPC: B21D37/16
Filed: 2002-10-31
Abstract: A can forming tool pack 2 includes internally cooled die modules 4, 6, 8. Each die module includes at least one die nib 14, 16, 18, 20, 22 held in a case. Fluid cooling medium is supplied to multiple inlets 24, 26, 28, 30 provided circumferentially in each case. The cooling fluid is channelled from the inlets through clearances 42, 44, 46, 48, 50 between an outer surface of the die nib and the case to cool the die nib. Outlets 34, 36, 38, 40 are spaced circumferentially around the case to return the cooling fluid to the medium supply
Patent NZ-533270-A (NZ)
Title: Reactive oil/copper preservative systems for wood products
Inventor: ROOS KENNETH D
IPC: B27K3/22
Filed: 2002-12-04
Abstract: The specification discloses preserved solid wood or wood composites including a copper ammonium acetate complex wood preservative and a drying oil. The wood preservative is present in the wood in an amount effective to improve the resistance of the treated wood to at least one type of decomposition, such as decay or insect attack. The drying oil is present in the wood in an effective amount to accomplish at least one useful end, such as reducing the water absorption or thickness swell of the treated wood or increasing its mechanical strength, even in a wood composite made using less binding resin than usual. A method of making the treated wood from green wood in solid or flaked form is also disclosed, wherein a copper ammonium acetate complex wood preservative and a drying oil are added to the green wood.
Patent NZ-535527-A (NZ)
Title: Lock system, lock system device and method of configuring a lock system
Inventor: PALOMAKI HILKKA
IPC: E05B49/00
Filed: 2003-03-12
Abstract: A method of configuring a lock system comprising a plurality of lock system devices comprises the following steps: defining a plurality of command and status messages, wherein each of the messages has a specific function when received by a device, defining a plurality of device types, wherein each of the types can send predetermined command and status messages, sending a claiming message from each device, wherein the claiming message from a specific device comprises information relating to the predetermined messages that said specific device can send, and storing, in each of the devices, the information relating to the predetermined messages that every other device can send. By this method, a simple lock system can be set up without involvement of the person installing the system. A lock system and a lock system device using this method are also provided.
Patent NZ-537278-A (NZ)
Title: Film coated tablet comprising a core of lasofoxifene tartrate
Inventor: GIERER DANIEL SCOTT
IPC: A61K9/20
Filed: 2003-06-30
Abstract: A pharmaceutical film coated tablet consisting of a tablet core, an opacifying coat and a polish coat wherein the tablet core consists of 0.341 mg lasofoxifene tartrate, 70.159 mg anhydrous lactose, 25.0 mg of microcrystalline cellulose, 3.0 mg croscarmellose sodium, 0.5 mg silicon dioxide and 1.0 mg magnesium stearate; the opacifying coat consists of 1.6 mg lactose monohydrate, 1.12 mg hydroxypropyl methyl cellulose 2910-15 cP, 0.94 mg titanium dioxide, 0.32 mg triacetin and 0.02 mg FD&C Yellow No. 6 Aluminium Lake 15%-18%; and the polish coat consists of 0.45 mg hydroxypropyl methylcellulose 291 0-l5cP and 0.05 mg triacetin. Alternatively the amount of lasofoxifene tartrate and anhydrous lactose in the above pharmaceutical film coated tablet can be 0.681 mg lasofoxifene tartrate and 69.819 mg anhydrous lactose.
Patent NZ-540108-A (NZ)
Title: New pyrrolidine and thiazolidine compounds, a process for their preparation, pharmaceutical compositions containing them and their use as inhibitors or dipeptidyl peptidase IV
Inventor: DE NANTEUIL GUILLAUME
IPC: C07D277/06
Filed: 2005-05-18
Abstract: Pyrrolidine and thiazolidine compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use as inhibitors of dipeptidyl peptidase IV (DPP IV) is disclosed, wherein X1, X2, X3, Ak, R1, R2, R3, m1, m2, n1, n2 and p are as defined in the specification. These compounds are suitable for use in the treatment of glucose intolerance, type II diabetes and disorders associated with hyperglycaemia.
Patent NZ-543943-A (NZ)
Title: Colchicoside analogues with muscle relaxant, anti-inflamatory and anti-gout activity
Inventor: BOMBARDELLI EZIO
IPC: A61P21/00
Filed: 2004-05-26
Abstract: Disclosed is a compound of the general formula (I) wherein X is oxygen or sulfur. Also disclosed is the use of the above compound for the preparation of anti-inflammatory medicaments, anti-gout medicaments or muscle relaxant medicaments.
Patent NZ-544824-A (NZ)
Title: Fingerprinting of data
Inventor: MALIK SUMIT
IPC: H04L9/00
Filed: 2004-03-31
Abstract: A fingerprinting system for fingerprinting media comprises a receiver to receive the media divided into a plurality of media segments and a first encoder to mark the media. The first encoder produces at least one marked media. Each of the marked media is divided into a plurality of marked media segments. A fingerprinting system for fingerprinting media further comprises a second encoder to compress the media and the at least one marked media and a selector to select the at least one marked media or marked media segments from one of the media and the at least one marked media and at least one combiner to arrange the selected at least one media or marked media segments to produce a fingerprinted media having a plurality of fingerprinted segments. The number of fingerprinted segments is equal to the number of media or marked media segments in each media or marked media.
Patent NZ-546265-A (NZ)
Title: Fluid reservoirs for penile implant devices that prevent blocking of the fluid reservoir outlet during use
Inventor: GEORGE STEPHANIE A
IPC: A61F5/00
Filed: 2004-10-01
Abstract: A fluid reservoir (118) for a penile implant device is disclosed. The reservoir includes a body (126) having a sleeve (134) from in which a tube (124) may extend. The body includes a support structure (138) positioned at an interior surface of the body near an orifice (127) of the reservoir (118) which orifice leads to the fluid passage (136) of the tube. The support structure may comprise a plurality of protrusions (140) that are arranged around the orifice (127) that extend from a base portion (142) of the body. The protrusions (140) help prevent the tube (124) becoming blocked by collapse of the reservoir (118). The invention also relates to a method of manufacturing a fluid reservoir for a penile implant device, which includes positioning a tube in a mould and injection moulding a reservoir body onto the tube. More particularly, the method may include providing a mould, positioning a tube in the mould, injecting material into the mould, curing the material, and opening the mould to remove the reservoir body and tube assembly.
Patent NZ-550477-A (NZ)
Title: Securing elements to pipes and tubes using a two part securing device that locks around the pipe or tube using a sliding movement
Inventor: RABANIN RAYMOND
IPC: F16L3/10
Filed: 2005-03-12
Abstract: A securing device for securing items to a pipe comprises a first part 4 and a second part 3 which can be positioned in engagement with each other when placed around a pipe. The first part 4 is placed behind a pipe and then the second part 3 is placed on the other side of the pipe below the first part 4. The then second part 3 is slid upwards until its flanges 10 enter into and engage with the recesses 15 on the first part 4. The surfaces of both the flanges 10 and the recesses 15 are inclined relative to the plane of the pipe such that the two parts of the securing device are drawn together as the second part 3 enters the first part 4. This drawing together of both parts of the device causes the device to grip the pipe when the two parts 3 4 of the device are approximately opposite to each other.
Patent NZ-553211-A (NZ)
Title: Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
Inventor: CORMIER YVON
IPC: A61K31/221
Filed: 2005-07-15
Abstract: This disclosure relates to nicotine receptor agonists or analogs or derivatives represented by the formula shown, wherein R1, R2, Xa and Ya are as defined in the specification. The use of nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases is also disclosed. The disclosure further relates to pharmaceutical compositions comprising nicotine receptor agonists or analogs or derivatives thereof.
Patent NZ-553621-A (NZ)
Title: Prevention and treatment of synucleinopathic and amyloidogenic disease
Inventor: SCHENK DALE B
IPC: A61K39/395
Filed: 2005-08-09
Abstract: Provided is the use of an antibody that specifically binds to an epitope within residues 1-20 of human alpha-synuclein, residues being numbered according to a specified sequence, for the manufacture of a medicament for prophylaxis or treatment of a disease characterized by Lewy bodies or alpha-synuclein aggregation in the brain. Further provided are similar uses of variants of the said antibody and methods of producing the antibody.
Patent NZ-562463-A (NZ)
Title: Wireless lan system and wireless communication method
Inventor: TSUTSUMI TAKAYUKI
IPC: H04W88/08
Filed: 2007-10-11
Abstract: A wireless LAN system is provided. The system includes a base station of a wireless LAN connected to a LAN terminal; and a number of wireless terminals connected to the base station. Each of the wireless terminals includes a means for executing a sleep mode in which the wireless terminal operates with low power; a means for notifying the base station of a broadcast/multicast (BC/MC) address for receiving data from the base station by BC/MC communication when the wireless terminal executes a program using the BC/MC communication in the wireless LAN; a means for switching the sleep mode to an awake mode and recognizing whether unicast data to be addressed to the wireless terminal by unicast communication is accumulated by the base station; a means for switching the awake mode to the sleep mode if the unicast data is not accumulated by the base station; and a means for notifying the base station of the switching to the awake mode from the sleep mode if the unicast data is accumulated by the base station. The base station includes a means for registering the BC/MC address notified from the wireless terminal as information related to an unicast address of the wireless terminal; a means for converting BC/MC data addressed to the wireless terminal and received from the LAN terminal into unicast data by rewriting a BC/MC address of the received BC/MC data by the unicast address related to the registered BC/MC address, which is the same as that of the BC/MC address; a means for sending information indicating that the unicast data is accumulated by the base station to the wireless terminal; and a means for transmitting the unicast data to the wireless terminal which has notified the base station of the switching to the awake mode from the sleep mode. A wireless communication method for the system is also provided.
Patent NZ-564695-A (NZ)
Title: Phage display using cotranslational translocation of fusion polypeptides
Inventor: STEINER DANIEL
Filed: 2006-06-30
Abstract: Disclosed is a filamentous phage display method wherein polypeptides of interest encoded by a DNA library are displayed on the phage particles. The DNA library is a cDNA library or a combinatorial DNA library that encodes a peptide library, an antibody library or a library based on alternative scaffolds. The polypeptides of interest are cotranslationally translocated across the cytoplasmic membrane of Gram-negative bacteria.
Patent NZ-569235-A (NZ)
Title: Compositions and methods for preserving brain function using medium chain triglycerides
Inventor: LARSON BRIAN T
IPC: A23L33/00
Filed: 2006-12-15
Abstract: Disclosed is the use of an effective amount of medium chain triglycerides (MCTs) composed of fatty acids, each independently having 5-12 carbons, esterified to a glycerol backbone, for the manufacture of a composition for preventing, reducing, or delaying decline in one or more of cognitive function, motor performance, cerebrovascular function, or behaviour in an aging mammal that has reached at least about 50 percent of its life expectancy, wherein the composition is adapted for administration on an extended regular basis for a period in excess of one month. Also disclosed is the method of establishing the prevention, reduction or delay of age-related cognitive impairment in a non-human animal.